Critical Illness
Conditions
Keywords
critical care unit
Brief summary
INDICAPS was the first large scale, multicentre survey launched by the ISCCM. The aim was to gather information about ICUs, organizational characteristics, patient casemix, the types and severity of illness, monitoring and therapeutic modalities used, types of infections, and other such data. This was performed between July 2010 and April 2011 and published in 2016.\[1\] Over the last 8 years, there has been a significant difference in the delivery of intensive care services, critical care education, socioeconomic indicators, antibiotic resistance patterns and other aspects of practices in Indian ICUs. It is therefore necessary to revisit and resurvey the current trends in intensive care practices in India, and to reflect the vast spectrum of critical care illness, services and practices. Similar to INDICAPS, which was a point-prevalence study of all patients present in the ICU on four different days over a one-year period, INDICAPS II will record data of all patients admitted to the ICU on 4 different days.
Detailed description
INDICAPS II will record data of all patients admitted to the ICU on 4 different days (August 23, 2018; October 25, 2018; December 13, 2018; April 11, 2019) in a cross-sectional design. Data collection includes: 1. On admission: demographic characteristics, comorbidities, source of admission, primary and secondary admission diagnoses, 2. Baseline data (on the study day), including parameters used to calculate SAPS II score and SOFA score and infections, 3. Information on monitoring modalities, mechanical ventilation, nutrition, fluid therapy, other routine ICU practices c. Outcome at ICU and hospital discharge d. Organisation of ICU services
Interventions
OTHERObservation
Observation
Sponsors
Indian Society of Critical Care Medicine
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* All patients present in the ICU on August 23, 2018; October 25, 2018; December 13, 2018; April 11, 2019
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ICU Mortality | 30 days from the study day | Number of patients who died in the ICU, as well as those terminally discharged from the ICU |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hospital Mortality | 30 days from the study day | all cause hospital mortality, including those terminally discharged from the ICU |
| ICU Length of Stay | upto 30 days from the study day | length of stay in the intensive care unit |
| Hospital Length of Stay | upto 30 days from the study day | length of stay in the hospital |
Countries
India
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Single Cohort All patients \> 15 years of age present in the intensive care unit on the study days | 4,669 |
| Total | 4,669 |
Baseline characteristics
| Characteristic | Single Cohort |
|---|---|
| Age > 15 years | 4669 Participants |
| Age, Continuous | 56.9 years STANDARD_DEVIATION 17.4 |
| Ethnicity (NIH/OMB) Asian (Indian) ethnicity 4669 Hispanic or Latino | 0 Participants |
| Ethnicity (NIH/OMB) Asian (Indian) ethnicity 4669 Not Hispanic or Latino | 0 Participants |
| Ethnicity (NIH/OMB) Asian (Indian) ethnicity 4669 Unknown or Not Reported | 4669 Participants |
| Region of Enrollment India | 4669 participants |
| Sex: Female, Male Female | 1696 Participants |
| Sex: Female, Male Male | 2973 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 1,164 / 4,669 |
| other Total, other adverse events | 0 / 4,669 |
| serious Total, serious adverse events | 0 / 4,669 |
Outcome results
Primary
ICU Mortality
Number of patients who died in the ICU, as well as those terminally discharged from the ICU
Time frame: 30 days from the study day
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Single Cohort | ICU Mortality | 1092 Participants |
Secondary
Hospital Length of Stay
length of stay in the hospital
Time frame: upto 30 days from the study day
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Single Cohort | Hospital Length of Stay | 12 Days |
Secondary
Hospital Mortality
all cause hospital mortality, including those terminally discharged from the ICU
Time frame: 30 days from the study day
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Single Cohort | Hospital Mortality | 1164 Participants |
Secondary
ICU Length of Stay
length of stay in the intensive care unit
Time frame: upto 30 days from the study day
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Single Cohort | ICU Length of Stay | 6 days |